Articles
PolyNovo gets US tick for NovoPore dressing
Calzada's (ASX:CZD) PolyNovo subsidiary has won 510(k) approval in the US for TNP foam dressing NovoPore, which has become the first approved product based on its NovoSorb technology. [ + ]
Viralytics kicks off STORM cancer trial
Viralytics (ASX:VLA) has commenced a clinical trial involving delivering multiple intravenous doses of Cavatak to treat late-stage melanoma, prostate, lung and metastatic bladder cancers. [ + ]
In-transition Novogen names new directors
Novogen (ASX:NRT) has named two new directors, including the lead inventor of its new ATM cancer drug platform, and revealed it swung to a 1H14 loss. [ + ]
Mesoblast well funded for next 2-3 years
Bell Potter Securities has maintained its 'buy' rating for Mesoblast shares - with a slightly reduced price target - on the strength of the company's 1H14 results. [ + ]
Calzada appoints new director, posts 1H14 results
Calzada (ASX:CZD) has appointed David Williams as a non-executive director and revealed it improved its cash position during 1H14. [ + ]
Nanoparticles, peptides and paper to detect cancer
Engineers at Massachusetts Institute of Technology (MIT) have developed a cheap and simple diagnostic, much like a pregnancy test, which detects cancer in urine samples. [ + ]
No progress for Pharma Patents Review
No plan to release the Pharmaceutical Patents Review Report, says Minister for Industry, Ian Macfarlane. [ + ]
'Microbial Pompeii' found on 1000-year-old teeth
Plaque on the teeth of 1000-year-old skeletons has preserved bacteria and microscopic particles of food, effectively creating a mineral tomb for microbiomes that has been unearthed by an international team of researchers. [ + ]
Ellex gets CE mark for laser eye treatment
Ellex Medical Lasers (ASX:ELX) has been granted approval to market 2RT - a laser therapy for chronic eye disease AMD - in the European Union. [ + ]
A complex biochemical system in a droplet
In an effort to investigate the reactions taking place in a biological cell, scientists tried to replicate them in an artificial cell. Such experiments have so far worked with very simple reactions, but the team managed to establish a complex biochemical reaction in tiny droplets only a few micrometres in size. [ + ]
Prana drug shows promise in Huntington's
Prana Biotechnology's (ASX:PBT) PBT2 candidate improved cognition at the highest dose level during a phase II trial in patients with Huntington's disease. [ + ]
What paused evolution?
The first life on Earth developed in the ancient oceans around 3.6 billion years ago but remained as little more than a layer of slime for a billion years. An international team of researchers has now revealed the ancient conditions that caused these events to occur. [ + ]
Microbattery to monitor migrating salmon
Scientists at the US Department of Energy's Pacific Northwest National Laboratory (PNNL) have created a microbattery to power an injectable transmitter, which will monitor the movements of salmon through rivers. [ + ]
Atomic structures and rotating anode sources
A new facility at the University of Melbourne's School of Physics has become home to a rotating anode source. The machine was installed by a team led by Professor Christopher Chantler, who noted that outside synchrotrons (of which there is only one in Australia), rotating anodes are one of the most powerful laboratory sources of X-rays. [ + ]
A neuroscientist's view
One of the founders of neuroscience in Australia, Professor Marcello Costa, reflects on a distinguished career as a research scientist, teacher, musician and philosopher. [ + ]

